Ten stocks close to their 52-week low
Ten stocks close to their 52-week low

Ten stocks close to their 52-week low

Abhishek Kapoor Article rating: 5.0

The market opened in the red on March 6, 2020. The previous trading session witnessed the Sensex going up by 61.13 points to end at 38,470.61 and the Nifty was up by 18 points to close at 11,269.00.

Another Black Friday for markets!
Another Black Friday for markets!

Another Black Friday for markets!

Karan Dsij Article rating: 4.7

Early signs from SGX Nifty indicate that it could be another Black Friday like the previous week, where Indian markets had cracked sharply. Our call for the day would be waiting for the market to settle after initial volatility, as there could be an initial reaction to Coronavirus, which is taking a toll on global economy and no one has the answer where this Coronavirus is heading and that’s the scary part.

Index trend and stocks in action on March 06, 2020
Index trend and stocks in action on March 06, 2020

Index trend and stocks in action on March 06, 2020

Karan Dsij Article rating: 5.0

If Nifty closes below 11,244, which is Thursday’s low, it will be an indication of the continuation of downtrend. However, a close below 11,000 level will have severe repercussions on the market. Stocks in news: Dr Reddy’s Laboratories, SBI, HCC, Lemon Tree, Pidilite Industries, Ester Industries, Agro Tech Foods.

Airtel partners with TCS for its HOBS PPM solution
Airtel partners with TCS for its HOBS PPM solution

Airtel partners with TCS for its HOBS PPM solution

Rishikesh Gaikwad Article rating: 4.6

Tata Consultancy Services (TCS) has successfully implemented TCS HOBS Product Portfolio Management (PPM) solution for Airtel. This will accelerate Airtel's digital transformation journey.

Zydus Cadila gets approval for liver disease drug
Zydus Cadila gets approval for liver disease drug

Zydus Cadila gets approval for liver disease drug

Pratik Shastri Article rating: 4.3

The company had filed an application for the abovementioned drug in December 2019. This has now become the first globally indicated drug for the treatment of NASH. Otherwise, there was no treatment available for this progressive liver disease.

Granules surge post USFDA nod for Potassium Chloride tablets
Granules surge post USFDA nod for Potassium Chloride tablets

Granules surge post USFDA nod for Potassium Chloride tablets

Apurva Joshi Article rating: 3.5

US Food & Drug Administration (USFDA) has approved Abbreviated New Drug Application (ANDA) filed by Granules Pharmaceuticals, Inc (GPI), a wholly-owned foreign subsidiary of Granules India Limited for Potassium Chloride Extended-Release Tablets USP, 8 mEq (600 mg) and 10 mEq (750 mg).

Rupee strengthens against US Dollar by 14 paise
Rupee strengthens against US Dollar by 14 paise

Rupee strengthens against US Dollar by 14 paise

Apurva Joshi Article rating: 5.0

Indian rupee gained against US dollar on Thursday, followed by firm domestic equities tracking global peers that gained on the back of former US Vice President Biden's big win, central banks' rate cut and World Bank's $12 billion aid package.

Andhra Bank reacts positively on stake hike by GoI
Andhra Bank reacts positively on stake hike by GoI

Andhra Bank reacts positively on stake hike by GoI

Pratik Shastri Article rating: 3.9

In terms of stock returns, PSU banks have performed very poorly, despite a consistent capital infusion by the government. Set of 18 PSU banking stocks has declined as much as 49 per cent since January 2019 till date.

Alembic Pharma gets USFDA nod for Doxycycline Hyclate tablets
Alembic Pharma gets USFDA nod for Doxycycline Hyclate tablets

Alembic Pharma gets USFDA nod for Doxycycline Hyclate tablets

Apurva Joshi Article rating: 5.0

Alembic Pharmaceuticals Limited has received final approval from US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Doxycycline Hyclate Tablets USP, 20 mg.

RSS
First28722873287428752877287928802881Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR